NYSE:NEUE NeueHealth (NEUE) Stock Price, News & Analysis $6.85 -0.09 (-1.30%) Closing price 03:59 PM EasternExtended Trading$6.83 -0.02 (-0.29%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About NeueHealth Stock (NYSE:NEUE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NeueHealth alerts:Sign Up Key Stats Today's Range$6.78▼$6.8650-Day Range$4.71▼$7.4552-Week Range$3.79▼$7.66Volume18,270 shsAverage Volume19,842 shsMarket Capitalization$56.75 millionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingHold Company OverviewNeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.Read More… Remove Ads NeueHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreNEUE MarketRank™: NeueHealth scored higher than 20% of companies evaluated by MarketBeat, and ranked 869th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingNeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNeueHealth has received no research coverage in the past 90 days.Read more about NeueHealth's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeueHealth is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeueHealth is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about NeueHealth's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.45% of the float of NeueHealth has been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeueHealth has recently increased by 33.70%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeueHealth does not currently pay a dividend.Dividend GrowthNeueHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.45% of the float of NeueHealth has been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeueHealth has recently increased by 33.70%, indicating that investor sentiment is decreasing significantly. News and Social Media1.0 / 5News Sentiment-0.13 News SentimentNeueHealth has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for NeueHealth this week, compared to 1 article on an average week. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $774,560.00 in company stock.Percentage Held by Insiders64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about NeueHealth's insider trading history. Receive NEUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NEUE Stock News HeadlinesNeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak Sells 4,448 SharesMarch 18, 2025 | insidertrades.comNeueHealth, Inc. (NYSE:NEUE) CEO Sells $91,337.40 in StockMarch 14, 2025 | insidertrades.comTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.March 28, 2025 | Porter & Company (Ad)NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 1,604 SharesMarch 12, 2025 | insidertrades.comNeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comQ4 2024 NeueHealth Inc Earnings CallMarch 21, 2025 | finance.yahoo.comNeueHealth, Inc (NEUE) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comNeueHealth: Q4 Earnings SnapshotMarch 20, 2025 | sfgate.comSee More Headlines NEUE Stock Analysis - Frequently Asked Questions How have NEUE shares performed this year? NeueHealth's stock was trading at $7.42 at the beginning of 2025. Since then, NEUE stock has decreased by 7.7% and is now trading at $6.85. View the best growth stocks for 2025 here. How were NeueHealth's earnings last quarter? NeueHealth, Inc. (NYSE:NEUE) posted its quarterly earnings data on Thursday, March, 20th. The company reported ($7.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.29) by $5.12. The business earned $232.64 million during the quarter, compared to analyst estimates of $261.80 million. NeueHealth had a negative net margin of 36.28% and a negative trailing twelve-month return on equity of 6.40%. Who are NeueHealth's major shareholders? NeueHealth's top institutional shareholders include Renaissance Technologies LLC (0.68%), Northern Trust Corp (0.39%), Virtu Financial LLC (0.12%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Jay Matushak, Tomas Orozco, Jeffery Michael Craig and Jeffrey J Scherman. View institutional ownership trends. How do I buy shares of NeueHealth? Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeueHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT). Company Calendar Last Earnings3/20/2025Today3/28/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryInsurance Current SymbolNYSE:NEUE Previous SymbolNYSE:NEUE CIK1671284 Webwww.brighthealthgroup.com Phone612-238-1321FaxN/AEmployees1,252Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+2.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($22.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,151,450,000.00 Net Margins-36.28% Pretax Margin-11.79% Return on Equity-6.40% Return on Assets8.45% Debt Debt-to-Equity RatioN/A Current Ratio0.68 Quick Ratio0.68 Sales & Book Value Annual Sales$936.66 million Price / Sales0.06 Cash Flow$57.08 per share Price / Cash Flow0.12 Book Value($158.35) per share Price / Book-0.04Miscellaneous Outstanding Shares8,285,000Free Float2,958,000Market Cap$56.75 million OptionableN/A Beta0.56 Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (NYSE:NEUE) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.